NGA
HRTX icon

Naples Global Advisors’s Heron Therapeutics HRTX Stock Holding History

Naples Global Advisors’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,400
Closed -$168K – 347
2020
Q2 		$168K Hold
11,400
– – 0.04% 326
2020
Q1 		$134K Buy
+11,400
New +$214K 0.04% 307

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Naples Global Advisors's HRTX Position: Q3 2020 in Review

Naples Global Advisors sold out of Heron Therapeutics (HRTX) in Q3 2020, closing a stake of 11,400 shares — an estimated $168K sold.

Naples Global Advisors first reported a position in HRTX in Q1 2020 and held it in 2 quarters. The position peaked at $168K in Q2 2020. 182 funds tracked by Wall St. Rank hold HRTX as of Q3 2020.

  • Naples Global Advisors reported no remaining Heron Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Naples Global Advisors sold 11,400 Heron Therapeutics shares in Q3 2020, an estimated $168K.
  • Naples Global Advisors first reported a position in Heron Therapeutics in Q1 2020 and held it in 2 quarters.
  • Naples Global Advisors's Heron Therapeutics position peaked at $168K in Q2 2020.
  • 182 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2020.

Based on Naples Global Advisors's 13F filing for Q3 2020, filed 26 Oct 2020.